J. Mackean

Concurrent chemoradiation for oesophageal cancer: factors influencing myelotoxicity.

B. Burmeister, J. Denham, D. Lamb, 1996, Australasian radiology.

The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy

J. Yaxley, T. Gianduzzo, B. Kua, 2019, Prostate Cancer and Prostatic Diseases.

Faculty of Radiation Oncology Position Paper on the use of Image–Guided Radiation Therapy

Tomas Kron, T. Kron, Albert Tiong, 2016, Journal of medical imaging and radiation oncology.

Oncological and urinary outcomes following low‐dose‐rate brachytherapy with a median follow‐up of 11.8 years

B. Delahunt, H. Samaratunga, L. Egevad, 2022, BJU international.

Long‐term outcomes of high‐dose‐rate brachytherapy for intermediate‐ and high‐risk prostate cancer with a median follow‐up of 10 years

H. Samaratunga, R. Gardiner, J. Yaxley, 2017, BJU international.

The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy

J. Yaxley, T. Gianduzzo, B. Kua, 2019, Prostate Cancer and Prostatic Diseases.